Taken together, it could be hypothesized that chronic active BCR signaling in ABC DLBCL relies primarily on CD79b, while CD79a contributes more to tonic BCR signaling in GCB DLBCL. This evidence concerns the gene CD79A and diffuse large B-cell lymphoma.